Heartflow (NASDAQ:HTFL) Stock Lifted to Buy by Wall Street Zen

Wall Street Zen upgraded shares of Heartflow (NASDAQ:HTFL) from a hold rating to a buy rating in a research report released on Saturday morning,Wall Street Zen reports.

HTFL has been the topic of several other research reports. Freedom Capital raised shares of Heartflow to a “strong-buy” rating in a research report on Tuesday, June 30th. Morgan Stanley boosted their target price on shares of Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research report on Friday, August 14th. Weiss Ratings upgraded shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. UBS Group initiated coverage on shares of Heartflow in a report on Wednesday, September 9th. They set a “neutral” rating and a $55.00 price target on the stock. Finally, Robert W. Baird set a $45.00 price objective on shares of Heartflow in a report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $46.25.

Heartflow Price Performance

Shares of NASDAQ HTFL opened at $49.32 on Friday. Heartflow has a one year low of $20.13 and a one year high of $52.22. The business’s 50-day moving average price is $42.57 and its two-hundred day moving average price is $33.55. The company has a market capitalization of $4.29 billion, a P/E ratio of -26.95 and a beta of 2.73.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. The company had revenue of $64.08 million during the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The firm’s revenue was up 47.7% on a year-over-year basis. On average, equities analysts anticipate that Heartflow will post -0.75 EPS for the current year.

Insider Buying and Selling at Heartflow

In related news, CFO Vikram Verghese sold 29,714 shares of the company’s stock in a transaction on Friday, September 11th. The shares were sold at an average price of $50.06, for a total transaction of $1,487,482.84. Following the completion of the sale, the chief financial officer directly owned 184,789 shares of the company’s stock, valued at approximately $9,250,537.34. This represents a 13.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Farquhar sold 35,010 shares of the firm’s stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $46.42, for a total transaction of $1,625,164.20. Following the completion of the transaction, the chief executive officer owned 325,804 shares in the company, valued at $15,123,821.68. The trade was a 9.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 287,767 shares of company stock worth $12,871,623 over the last 90 days. Insiders own 7.70% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. XXEC Inc. acquired a new stake in shares of Heartflow in the second quarter valued at about $2,524,764,000. BlackRock Inc. bought a new stake in Heartflow during the 2nd quarter valued at approximately $152,502,000. Bamco Inc. NY bought a new stake in Heartflow during the 2nd quarter valued at approximately $94,625,000. Jupiter Topco LLC acquired a new stake in Heartflow in the 2nd quarter valued at approximately $70,983,000. Finally, Janus Henderson Group PLC increased its position in Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after buying an additional 1,315,416 shares during the period.

About Heartflow

HeartFlow, Inc is a medical technology company focused on improving the diagnosis and management of coronary artery disease. The company develops software and clinical tools that use artificial intelligence, advanced image analysis and data from coronary computed tomography angiography (CCTA) scans to provide noninvasive assessments of blood flow and potential blockages in the heart.

Its principal product is the HeartFlow Analysis, which creates a personalized, three-dimensional model of a patient’s coronary arteries and can estimate the impact of blockages on blood flow.